Summary
The ability to generate, maintain, and use cloned lines of T cells reactive for self-antigens has opened up a new avenue of investigation for researchers. These T-cell clones allow the rapid induction of tissue-specific autoimmunity with the intent of dissecting the contribution of the different cell types involved. T cells from the diabetes-prone nonobese diabetic mouse are proving to be a vital asset for understanding the T-cell-mediated pathogenesis that leads to overt β-cell destruction. T-cell clone adoptive transfer protocols have been developed for use in immunodeficient strains, thus reducing the complexity of mechanism of disease initiation. Furthermore, these T-cell clones have been used to derive T-cell receptor transgenic (TCR-Tg) animals carrying only self-reactive T cells. The use of these TCR-Tg animals to study pathogenesis has also evolved from the ability to generate, maintain, and use T-cell cloned lines. This chapter focuses on primary culture for the generation of T-cell lines and clones, their long-term maintenance, and their use in disease transfer for studying the pathogenesis of end-organ autoimmunity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Greiner, D. L., Rossini, A. A., and Mordes, J. P. (2001) Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere. Clin. Immunol. 100, 134–143.
Eisenbarth, G. S. (1993) Molecular aspects of the etiology of type I diabetes mellitus. J Diabetes Complications 7, 142–50.
Bach, J. F. (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrinology Rev. 4, 516–542.
Christianson, S. W., Shultz, L. D., and Leiter, E. H. (1993) Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic vs prediabetic NOD.NON-Thy-1a donors. Diabetes 42, 44–55.
Haskins, K., Portas, M., Bradley, B., Wegmann, D., and Lafferty, K. (1988) Tlymphocyte clone specific for pancreatic islet antigen. Diabetes 37, 1444–1448.
Haskins, K., Portas, M., Bergman, B., Lafferty, K., and Bradley, B. (1989) Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 86, 8000–8004.
Haskins, K. and McDuffie, M. (1990) Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249, 1433–1436.
Miller, B. J., Appel, M. C., O’Neil, J. J., and Wicker, L. S. (1988) Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140, 52–58.
O’Reilly, L. A., Hutchings, P. R., Crocker, P. R., Simpson, E., Lund, T., Kioussis, D., et al. (1991) Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur. J. Immunol. 21, 1171–1180.
DiLorenzo, T. P., Graser, R. T., Ono, T., Christianson, G. J., Chapman, H. D., Roopenian, D. C., et al. (1998) Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95, 12,538–12,543.
Serreze, D. V., Chapman, H. D., Varnum, D. S., Gerling, I., Leiter, E. H., and Shultz, L. D. (1997) Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. 158, 3978–3986.
Graser, R. T., DiLorenzo, T. P., Wang, F., Christianson, G. J., Chapman, H. D., Roopenian, D. C., et al. (2000) Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J. Immunol. 164, 3913–3918.
Katz, J. D., Wang, B., Haskins, K., Benoist, C., and Mathis, D. (1993) Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089–1100.
Poulin, M. and Haskins, K. (2000) Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse. J. Immunol. 164, 3072–3078.
Peterson, J. D., Pike, B., McDuffie, M., and Haskins, K. (1994) Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice. J. Immunol. 153, 2800–2806.
Peterson, J. D., Berg, R., Piganelli, J. D., Poulin, M., and Haskins, K. (1998) Analysis of leukocytes recruited to the pancreas by diabetogenic T cell clones. Cell Immunol. 189, 92–98.
Dobbs, C. M. and Haskins, K. (2001) Comparison of a T cell clone and of T cells from a TCR transgenic mouse: TCR transgenic T cells specific for self-antigen are atypical. J. Immunol. 166, 2495–2504.
Piganelli, J. D., Flores, S. C., Cruz, C., Koepp, J., Batinic-Haberle, I., Crapo, J., et al. (2002) A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes 51, 347–355.
Metzger, Z., Hoffeld, J. T., and Oppenheim, J. J. (1980) Macrophage-mediated suppression. I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J. Immunol. 124, 983–988.
Ablamunits, V., Elias, D., and Cohen, I. R. (1999). The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Clin. Exp. Immunol. 115, 260–267.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Milton, M.J., Poulin, M., Mathews, C., Piganelli, J.D. (2004). Generation, Maintenance, and Adoptive Transfer of Diabetogenic T-Cell Lines/Clones From the Nonobese Diabetic Mouse. In: Perl, A. (eds) Autoimmunity. Methods in Molecular Medicine™, vol 102. Humana Press. https://doi.org/10.1385/1-59259-805-6:213
Download citation
DOI: https://doi.org/10.1385/1-59259-805-6:213
Publisher Name: Humana Press
Print ISBN: 978-1-58829-231-5
Online ISBN: 978-1-59259-805-2
eBook Packages: Springer Protocols